Long‐term effects on glycaemic control and β‐cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial

2018 ◽  
Vol 20 (5) ◽  
pp. 1121-1130 ◽  
Author(s):  
Suk Chon ◽  
Sang Youl Rhee ◽  
Kyu Jeung Ahn ◽  
Sei Hyun Baik ◽  
Yongsoo Park ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Randomized Trial ◽  
Intensive Treatment ◽  
Newly Diagnosed ◽  
Long Term Effects ◽  
Β Cell ◽  
Cell Preservation

Treatment of depression in type 2 diabetes

2018 ◽  
Author(s):  
Frank Petrak ◽  
Bonnie Röhrig
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Scientific Evidence ◽  
Psychological Interventions ◽  
Long Term Effects ◽  
Pharmacological Interventions ◽  
Treatment Of Depression ◽  
Depressive Patients

This chapter provides a brief overview of the current scientific evidence for the treatment of depression in type 2 diabetes. Considering the multiple adverse interactions between both conditions, treatment targets should always focus on diabetes-related medical outcome and improvement or remission of depression at the same time in people with diabetes. Depression can be treated with moderate to good results in depressed patients with type 2 diabetes by a variety of psychological and pharmacological interventions, with comparable results to the treatment of depressive patients without diabetes. Results regarding glycaemic control are inconsistent and indicate a low effectiveness of psychological interventions. Antidepressants demonstrated mild to moderate effect regarding better glycaemic control, but the results are still inconclusive and long-term effects are widely unknown. The chapter ends with a critical summary of methodological limitations of the research in that area and concludes with evidence-based recommendations for clinical practice.

Sign in / Sign up

Export Citation Format

Share Document